Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

Loc Performance Products Expands With Acquisition in Lansing, Michigan

06/29/2018
Loc Performance Products, a full-service provider of complex mechanical systems, fabricated structures and armor products for defense and commercial industries, recently acquired the assets of Demmer Corporation in Lansing, Michigan. The acquisition allowed the company to expand its manufacturing capabilities.

According to the Michigan Strategic Fund, Loc is winning substantial defense contracts and plans to continue expansion at the Demmer facility; the company may potentially seek to build or purchase a new facility in the Lansing region if capacity is exceeded at the Demmer facility.

The project is expected to generate a total capital investment of $96.5 million and create 700 jobs, resulting in a $7 million Michigan Business Development Program performance-based grant.

“This is a tremendous investment in the City of Lansing. I am proud that Loc Performance Products chose Lansing for its expansion,” said Lansing Mayor Andy Schor. “Lansing’s talented workforce will benefit from the many new jobs that will be created as a result of the major investment in our city.”

“LEAP thanks LOC for choosing our state and Lansing over other alternative locations. We’re always in severe national and global competition and we have now won 700 great, new jobs for our families in Michigan and Lansing,” said LEAP President & CEO Bob Trezise. “Thanks also to a terrific MEDC effort on this project.”

“The Michigan Strategic Fund fuels new economic activity across Michigan, strengthening our communities and creating good jobs,” said Jeff Mason, CEO of MEDC, the state’s chief marketing and business attraction arm that administers programs and performs due diligence on behalf of the MSF.

Exclusive Research